Cytokinetics Renews Partnership With The ALS Association

Cytokinetics Renews Partnership With The ALS Association

294986

Cytokinetics Renews Partnership With The ALS Association

Cytokinetics has reaffirmed its partnership with The ALS Association in the fight against amyotrophic lateral sclerosis (ALS) by continuing to support events and initiatives throughout 2021. The muscle biology biopharmaceutical company also is working to advance the clinical development of its experimental therapy reldesemtiv, designed to improve muscle function in ALS patients. “We are proud to renew our enduring partnership and continue our support for The ALS Association and The ALS Association Golden West Chapter…

You must be logged in to read/download the full post.